Other
Accounts Receivable, Allowance for Credit Loss
Labcorp Holdings Accounts Receivable, Allowance for Credit Loss decreased by 9.3% to $33.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.5%, from $38.60M to $33.00M. Over 5 years (FY 2020 to FY 2025), Accounts Receivable, Allowance for Credit Loss shows an upward trend with a 10.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ4 2019
Last reportedQ2 2025
How to read this metric
An increasing allowance relative to receivables may signal deteriorating credit quality among clients.
Detailed definition
This is a contra-asset account representing the estimated amount of accounts receivable that the company does not expect...
Peer comparison
Standard across service industries; levels are compared against historical write-off rates.
Metric ID:
other_allowance_for_doubtful_accounts_receivableHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.90M | $18.30M | $21.50M | $19.40M | $21.30M | $20.50M | $30.70M | $52.80M | $30.60M | $32.80M | $32.70M | $34.20M | $34.10M | $38.90M | $44.70M | $38.60M | $40.10M | $36.70M | $36.40M | $33.00M |
| QoQ Change | — | -12.4% | +17.5% | -9.8% | +9.8% | -3.8% | +49.8% | +72.0% | -42.0% | +7.2% | -0.3% | +4.6% | -0.3% | +14.1% | +14.9% | -13.6% | +3.9% | -8.5% | -0.8% | -9.3% |
| YoY Change | — | — | — | — | +1.9% | +12.0% | +42.8% | +172.2% | +43.7% | +60.0% | +6.5% | -35.2% | +11.4% | +18.6% | +36.7% | +12.9% | +17.6% | -5.7% | -18.6% | -14.5% |
Range$18.30M – $52.80M
CAGR+10.1%
Avg YoY Growth+22.6%
Median YoY Growth+12.4%
Current Streak3 quarters decline
Business Segments
| Segment | Q4 '24 | Q4 '25 |
|---|---|---|
| Biopharma Laboratory Services | $44.70M | $36.40M |
| Total | $44.70M | $36.40M |
Accounts Receivable, Allowance for Credit Loss at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's accounts receivable, allowance for credit loss?
- Labcorp Holdings (LH) reported accounts receivable, allowance for credit loss of $33.00M in Q1 2026.
- How has Labcorp Holdings's accounts receivable, allowance for credit loss changed year-over-year?
- Labcorp Holdings's accounts receivable, allowance for credit loss decreased by 14.5% year-over-year, from $38.60M to $33.00M.
- What is the long-term trend for Labcorp Holdings's accounts receivable, allowance for credit loss?
- Over 5 years (2020 to 2025), Labcorp Holdings's accounts receivable, allowance for credit loss has grown at a 10.5% compound annual growth rate (CAGR), from $22.10M to $36.40M.
- What does accounts receivable, allowance for credit loss mean?
- The estimated portion of customer invoices that will likely go unpaid.